The struggling biotech firm, NovaGen Therapeutics, faced significant monetary difficulties stemming from disappointing clinical trials and mounting debt. Their internal leadership lacked the expertise to https://estelleirpb838095.aboutyoublog.com/52593680/biotech-cfo-services-a-case-study-in-fiscal-recovery